Anteris Technologies Ltd
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AVR.AX research report →
Price Chart
About the company
Anteris Technologies Ltd is a firm specializing in the structural heart domain. It is responsible for the production and distribution of ADAPT, a product based on regenerative tissue technology. The company is also actively involved in advancing DurAVR™, an innovative 3D single-component aortic valve specifically designed for treating aortic stenosis.
- CEO
- Wayne Geoffrey Paterson
- IPO
- 2004
- Employees
- 174
- HQ
- Toowong, QLD, AU
Get TickerSpark's AI analysis on AVR.AX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $1.23B
- P/E
- -3.49
- PEG
- 0.24
- P/S
- 315.23
- P/B
- 3.25
- EV/EBITDA
- -4.99
- Div Yield
- 0.00%
- Gross Margin
- 72.55%
- Op Margin
- -4574.84%
- Net Margin
- -4482.38%
- ROE
- -99.78%
- ROIC
- -50.15%
Latest fiscal year · YoY change
- Revenue
- $1.91M-29.2%
- Gross Profit
- $1.34M+6.2%
- Op Income
- $-93,894,000
- Net Income
- $-94,144,000-23.4%
- EPS
- $-2.61+30.8%
- OCF Growth
- -27.0%
- FCF Growth
- -25.6%
- 52W High
- $15.47
- 52W Low
- $5.20
- 50D MA
- $12.82
- 200D MA
- $9.46
- Beta
- 0.73
- RSI (14)
- 52
- Avg Volume
- 20.19K
No earnings-call transcripts are available for AVR.AX yet.
- Free Float
- 99.9%
- Shares Outstanding
- 97.34M
- Float Shares
- 97.22M
Our AVR.AX coverage
Recent articles, reports, and earnings notes.
No research on AVR.AX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate AVR.AX report →Pennon returns to profit after water bill hikes
proactiveinvestors.com · Jun 10
Anteris adds Susan Knight, Stephen Denaro to board as company advances heart valve strategy
proactiveinvestors.com · May 13
Anteris advances PARADIGM trial as Q1 cash burn reflects commercialisation push
proactiveinvestors.com · May 13
Anteris Announces Results for the First Quarter of 2026
globenewswire.com · May 12
Whirlpool cuts forecast, suspends dividend as Iran war hammers demand
proactiveinvestors.com · May 7
Dow Jones set for flat start as market await Iran response to US peace deal
proactiveinvestors.com · May 7
JD Sports preview: signs of recovery in focus ahead of World Cup
proactiveinvestors.com · May 6
Voyager Technologies narrows loss in Q1 as revenue comes in below expectations
proactiveinvestors.com · May 6
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.